Delivery Order SPE2DB22D3301-SPE2DB24FY5BY
Award Date
4/19/24
Potential Completion Date
4/22/24
Potential Value
$41K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML prescription medication to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,838.96 and is a Firm Fixed Price Delivery Order that runs through April 24, 2024. The contract is not set aside and was awarded under the company's existing...
The federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type, valued at $62,258.80, and has an ultimate completion date of January 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with any set-aside requirements, indicating open...
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products to the Defense Logistics Agency (DLA). The $6,909.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 1, 2024 and does not include any set-aside requirements. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,443.52 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 5, 2024. The contract has an ultimate completion date of December 6, 2024 and is not designated as a set-aside. Amerisourcebergen maintains a $999,999,999...
This federal contract award is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,695.04, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), as a firm fixed-price delivery order. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,261.76 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a comprehensive range of pharmaceutical and medical supplies to Department of Defense facilities worldwide....
This federal contract award is for the delivery of the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,630.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with a completion date of August 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award, valued at $1,375.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a completion date of December 6, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, and it does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,384.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...